TME Pharma N.V. (EPA:ALTME)
France
· Delayed Price · Currency is EUR 0.0725
-0.0005 (-0.68%)
May 16, 2025, 5:28 PM CET
TME Pharma Revenue
In the year 2024, TME Pharma had annual revenue of 19.00K EUR with 11.76% growth. TME Pharma had revenue of 19.00K in the half year ending December 31, 2024.
Revenue
19.00K
Revenue Growth
+11.76%
P/S Ratio
359.11
Revenue / Employee
1.58K
Employees
12
Market Cap
6.82M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sanofi | 45.17B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |